Skip to main content
. 2023 Jul 13;11(7):1989. doi: 10.3390/biomedicines11071989

Table 1.

Results of all GBM patients.

Group Subgroups Group Size MST (Months)
Historical control Treated with radiotherapy 12.1
Treated with radiotherapy + TMZ 14.6
All 55 patients 55 30 (95% CI: 9.4–50.5)
Treated without TMZ 38 27 (95% CI: 18.8–35.1)
Treated with TMZ 17 42 (95% CI: 14.6–69.3)
Males 33 25 (95% CI: 15.9–34.0)
Females 22 42 (95% CI: 18.3–65.6)
Selected 31 patients 30 (95% CI: 0.5–59.4)
In relapse at the beginning of DDW treatment 20 30 (95% CI: 22.6–37.3)
In remission at the beginning of DDW treatment 10 47 (95% CI: 0.0–0.0)
DDW along with radiotherapy 24 47 (95% CI: 18.8–75.1)
DDW after radiotherapy 7 25 (95% CI: 14.5–35.4)